Microsoft Word - RadBio_Programme_ParisSept2017_verAug31

1506-1507 / 2063

Eriksen Radiother Oncol 2005
EGFR expression & prognosis
HR 0.62
HR 0.70
HNSCC with high EGFr
expression respond
better to moderately
accelerated
radiotherapy than
tumors with low EGFr
DAHANCA 6 and 7